202 related articles for article (PubMed ID: 38136175)
1. BET Protein Inhibitor JQ1 Ameliorates Experimental Peritoneal Damage by Inhibition of Inflammation and Oxidative Stress.
Marchant V; Trionfetti F; Tejedor-Santamaria L; Rayego-Mateos S; Rotili D; Bontempi G; Domenici A; Menè P; Mai A; Martín-Cleary C; Ortiz A; Ramos AM; Strippoli R; Ruiz-Ortega M
Antioxidants (Basel); 2023 Nov; 12(12):. PubMed ID: 38136175
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Bromodomain and Extraterminal Domain Family Proteins Ameliorates Experimental Renal Damage.
Suarez-Alvarez B; Morgado-Pascual JL; Rayego-Mateos S; Rodriguez RM; Rodrigues-Diez R; Cannata-Ortiz P; Sanz AB; Egido J; Tharaux PL; Ortiz A; Lopez-Larrea C; Ruiz-Ortega M
J Am Soc Nephrol; 2017 Feb; 28(2):504-519. PubMed ID: 27436852
[TBL] [Abstract][Full Text] [Related]
3. Differential responses of pulmonary vascular cells from PAH patients and controls to TNFα and the effect of the BET inhibitor JQ1.
Mumby S; Perros F; Grynblat J; Manaud G; Papi A; Casolari P; Caramori G; Humbert M; John Wort S; Adcock IM
Respir Res; 2023 Jul; 24(1):193. PubMed ID: 37516840
[TBL] [Abstract][Full Text] [Related]
4. BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction.
Meng S; Zhang L; Tang Y; Tu Q; Zheng L; Yu L; Murray D; Cheng J; Kim SH; Zhou X; Chen J
J Dent Res; 2014 Jul; 93(7):657-62. PubMed ID: 24799421
[TBL] [Abstract][Full Text] [Related]
5. The suppression of bromodomain and extra-terminal domain inhibits vascular inflammation by blocking NF-κB and MAPK activation.
Huang M; Zeng S; Zou Y; Shi M; Qiu Q; Xiao Y; Chen G; Yang X; Liang L; Xu H
Br J Pharmacol; 2017 Jan; 174(1):101-115. PubMed ID: 27774624
[TBL] [Abstract][Full Text] [Related]
6. Bromodomain and Extraterminal (BET) Protein Inhibition Restores Redox Balance and Inhibits Myofibroblast Activation.
Stock CJW; Michaeloudes C; Leoni P; Durham AL; Mumby S; Wells AU; Chung KF; Adcock IM; Renzoni EA; Lindahl GE
Biomed Res Int; 2019; 2019():1484736. PubMed ID: 31119153
[TBL] [Abstract][Full Text] [Related]
7. Co-inhibition of BET proteins and NF-κB as a potential therapy for colorectal cancer through synergistic inhibiting MYC and FOXM1 expressions.
Wu T; Wang G; Chen W; Zhu Z; Liu Y; Huang Z; Huang Y; Du P; Yang Y; Liu CY; Cui L
Cell Death Dis; 2018 Feb; 9(3):315. PubMed ID: 29472532
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of BET Protein Function Suppressed the Overactivation of the Canonical NF-κB Signaling Pathway in 6-OHDA-Lesioned Rat Model of Levodopa-Induced Dyskinesia.
Wan Y; Han L; Rong L; Yang S; Song L; Wu N; Liu Z; Gan J
Front Neurosci; 2022; 16():896322. PubMed ID: 35801173
[TBL] [Abstract][Full Text] [Related]
9. BET Protein Inhibitor JQ1 Modulates Mitochondrial Dysfunction and Oxidative Stress Induced by Chronic Kidney Disease.
Rayego-Mateos S; Basantes P; Morgado-Pascual JL; Brazal Prieto B; Suarez-Alvarez B; Ortiz A; Lopez-Larrea C; Ruiz-Ortega M
Antioxidants (Basel); 2023 May; 12(5):. PubMed ID: 37237996
[TBL] [Abstract][Full Text] [Related]
10. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
[TBL] [Abstract][Full Text] [Related]
11. Bromodomain and extra-terminal domain bromodomain inhibition prevents synovial inflammation via blocking IκB kinase-dependent NF-κB activation in rheumatoid fibroblast-like synoviocytes.
Xiao Y; Liang L; Huang M; Qiu Q; Zeng S; Shi M; Zou Y; Ye Y; Yang X; Xu H
Rheumatology (Oxford); 2016 Jan; 55(1):173-84. PubMed ID: 26324948
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of the BET protein inhibitor JQ1 in cisplatin-induced nephrotoxicity.
Sun L; Liu J; Yuan Y; Zhang X; Dong Z
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F469-F478. PubMed ID: 29767555
[TBL] [Abstract][Full Text] [Related]
13. Bromodomain and Extraterminal (BET) protein inhibition suppresses tumor progression and inhibits HGF-MET signaling through targeting cancer-associated fibroblasts in colorectal cancer.
Wen D; Wang Y; Zhu Z; Huang Z; Cui L; Wu T; Liu CY
Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165923. PubMed ID: 32800944
[TBL] [Abstract][Full Text] [Related]
14. BET Bromodomain Blockade Mitigates Intimal Hyperplasia in Rat Carotid Arteries.
Wang B; Zhang M; Takayama T; Shi X; Roenneburg DA; Kent KC; Guo LW
EBioMedicine; 2015 Nov; 2(11):1650-61. PubMed ID: 26870791
[TBL] [Abstract][Full Text] [Related]
15. RNA sequencing reveals distinct mechanisms underlying BET inhibitor JQ1-mediated modulation of the LPS-induced activation of BV-2 microglial cells.
Jung KH; Das A; Chai JC; Kim SH; Morya N; Park KS; Lee YS; Chai YG
J Neuroinflammation; 2015 Feb; 12():36. PubMed ID: 25890327
[TBL] [Abstract][Full Text] [Related]
16. Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responses.
Remke N; Bisht S; Oberbeck S; Nolting J; Brossart P
Cancer Immunol Immunother; 2021 Jan; 70(1):107-121. PubMed ID: 32651619
[TBL] [Abstract][Full Text] [Related]
17. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
[TBL] [Abstract][Full Text] [Related]
18. Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer.
Luan W; Pang Y; Li R; Wei X; Jiao X; Shi J; Yu J; Mao H; Liu P
Onco Targets Ther; 2019; 12():8063-8074. PubMed ID: 31632060
[TBL] [Abstract][Full Text] [Related]
19. The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs.
Liu PY; Sokolowski N; Guo ST; Siddiqi F; Atmadibrata B; Telfer TJ; Sun Y; Zhang L; Yu D; Mccarroll J; Liu B; Yang RH; Guo XY; Tee AE; Itoh K; Wang J; Kavallaris M; Haber M; Norris MD; Cheung BB; Byrne JA; Ziegler DS; Marshall GM; Dinger ME; Codd R; Zhang XD; Liu T
Oncotarget; 2016 Nov; 7(48):79217-79232. PubMed ID: 27764794
[TBL] [Abstract][Full Text] [Related]
20. BET bromodomain inhibition of MYC-amplified medulloblastoma.
Bandopadhayay P; Bergthold G; Nguyen B; Schubert S; Gholamin S; Tang Y; Bolin S; Schumacher SE; Zeid R; Masoud S; Yu F; Vue N; Gibson WJ; Paolella BR; Mitra SS; Cheshier SH; Qi J; Liu KW; Wechsler-Reya R; Weiss WA; Swartling FJ; Kieran MW; Bradner JE; Beroukhim R; Cho YJ
Clin Cancer Res; 2014 Feb; 20(4):912-25. PubMed ID: 24297863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
